Unknown

Dataset Information

0

N-acetylcysteine for non-paracetamol drug-induced liver injury: a systematic review.


ABSTRACT: N-acetylcysteine (NAC) may be useful in the management of non-paracetamol drug-induced liver injury (DILI). Our objective was to review systematically evidence for the use of NAC as a therapeutic option for non-paracetamol DILI.We searched for randomized controlled trials (RCTs) and prospective cohort studies. We searched several bibliographic databases, grey literature sources, conference proceedings and ongoing trials. Our pre-specified primary outcomes were all cause and DILI related mortality, time to normalization of liver biochemistry and adverse events. Secondary outcomes were proportion receiving liver transplant, time to transplantation, transplant-free survival and hospitalization duration.We identified one RCT of NAC vs. placebo in patients with non-paracetamol acute liver failure. There was no difference in the primary outcomes of overall survival at 3 weeks between NAC [70%, 95% confidence interval (CI) = 60%, 81%, n = 81] and placebo (66%, 95% CI = 56%, 77%, n = 92). NAC significantly improved the secondary outcomes of transplant-free survival compared with placebo: 40% NAC (95% CI = 28%, 51%) vs. 27% placebo (95% CI = 18%, 37%). A subgroup analysis according to aetiology found improved transplant-free survival in patients with non-paracetamol DILI, NAC (58%, n = 19) vs. placebo (27%, n = 26), odds ratio (OR) 0.27 (95% CI = 0.076, 0.942). Overall survival was similar, NAC (79%) vs. placebo (65%);, OR 0.50 (95% CI = 0.13, 1.98).Current available evidence is limited and does not allow for any firm conclusions to be made regarding the role of NAC in non-paracetamol DILI. We therefore highlight the need for further research in this area.

SUBMITTER: Chughlay MF 

PROVIDER: S-EPMC4876182 | biostudies-other | 2016 Jun

REPOSITORIES: biostudies-other

altmetric image

Publications

N-acetylcysteine for non-paracetamol drug-induced liver injury: a systematic review.

Chughlay Mohamed Farouk MF   Kramer Nicole N   Spearman C Wendy CW   Werfalli Mahmoud M   Cohen Karen K  

British journal of clinical pharmacology 20160302 6


<h4>Aims</h4>N-acetylcysteine (NAC) may be useful in the management of non-paracetamol drug-induced liver injury (DILI). Our objective was to review systematically evidence for the use of NAC as a therapeutic option for non-paracetamol DILI.<h4>Methods</h4>We searched for randomized controlled trials (RCTs) and prospective cohort studies. We searched several bibliographic databases, grey literature sources, conference proceedings and ongoing trials. Our pre-specified primary outcomes were all ca  ...[more]

Similar Datasets

| S-EPMC7160354 | biostudies-literature
| S-EPMC8847672 | biostudies-literature
2014-01-22 | E-GEOD-54257 | biostudies-arrayexpress
| S-EPMC5019919 | biostudies-literature
| S-EPMC5765191 | biostudies-literature
2014-01-22 | GSE54257 | GEO
| S-EPMC3681898 | biostudies-literature
| S-EPMC8725884 | biostudies-literature
| S-EPMC8467059 | biostudies-literature
| S-EPMC7288225 | biostudies-literature